MedTrace Logo

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

NCT05336825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-20

No results posted yet for this study

Summary

CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on young women and compare it to topical lidocaine.

Conditions

  • Vulvodynia

Interventions

DEVICE

CO2 laser

Mona Lisa CO2 laser

DRUG

Lidocaine patch 5%

lidocaine

Sponsors & Collaborators

  • Foundation for Morristown Medical Center

    collaborator UNKNOWN

  • Atlantic Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-01-31
Completion
2021-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05336825 on ClinicalTrials.gov